The characteristics of invasive breast cancer in women who use and do not use hormone replacement therapy in the million women study.

The characteristics of invasive breast cancer in women who use and do not use hormone replacement therapy in the million women study.

Bibliografske podrobnosti
Main Authors:	Gathani, T, Green, J, Reeves, G, Beral, V
Format:	Conference item
Izdano:	2006

Podobne knjige/članki

Characteristics of women who undergo breast reconstruction following mastectomy for breast cancer in the Million Women Study
od: Gathani, T, et al.
Izdano: (2014)

Ovarian cancer and hormone replacement therapy in the Million Women Study.
od: Beral, V, et al.
Izdano: (2007)

Breast cancer and hormone-replacement therapy: the Million Women Study - Reply
od: Beral, V, et al.
Izdano: (2003)

Breast cancer and hormone-replacement therapy in the Million Women Study.
od: Beral, V
Izdano: (2003)

Published results on breast cancer and hormone replacement therapy in the Million Women Study are correct.
od: Banks, E, et al.
Izdano: (2004)

Endometrial cancer and hormone-replacement therapy in the Million Women Study.
od: Beral, V, et al.
Izdano: (2005)

Published results on breast cancer and hormone replacement therapy in the Million Women Study are correct (multiple letters)
od: Banks, E, et al.
Izdano: (2004)

Hormone replacement therapy and incidence of central nervous system tumours in the Million Women Study.
od: Benson, V, et al.
Izdano: (2010)

Impact of hormone replacement therapy on breast cancer
od: Gathani, T, et al.
Izdano: (2010)

Variations in the Prevalence of Risk Factors for Breast Cancer in Different Ethnic Groups in the Million Women Study
od: Gathani, T, et al.
Izdano: (2012)

Breast cancer and hormone-replacement therapy: the Million Women Study.
od: Bliss, J, et al.
Izdano: (2003)

Cohort Profile: the Million Women Study
od: Green, J, et al.
Izdano: (2018)

Hormone replacement therapy and false positive recall in the Million Women Study: patterns of use, hormonal constituents and consistency of effect.
od: Banks, E, et al.
Izdano: (2006)

Characteristics of the Million Women Study participants who have and have not worked at night.
od: Wang, X, et al.
Izdano: (2012)

Impact of use of hormone replacement therapy on false positive recall in the NHS breast screening programme: results from the Million Women Study.
od: Banks, E, et al.
Izdano: (2004)

Characteristics of the Million Women Study participants who have and have not worked at night
od: Xiao-Si Wang, et al.
Izdano: (2012-11-01)

Patterns of use of hormone replacement therapy in one million women in Britain, 1996-2000.
od: Million Women Study Collaborators
Izdano: (2002)

Gallbladder disease and use of transdermal versus oral hormone replacement therapy in postmenopausal women: prospective cohort study.
od: Liu, B, et al.
Izdano: (2008)

Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis.
od: Reeves, G, et al.
Izdano: (2006)

Pathology reports provided reliable and readily accessible records of surgical procedures performed in women with breast cancer.
od: Gathani, T, et al.
Izdano: (2008)

Gallbladder disease and use of transdermal versus oral hormone replacement therapy in postmenopausal women: prospective cohort study
od: Liu, B, et al.
Izdano: (2008)

Ethnicity and the tumour characteristics of invasive breast cancer in over 116,500 women in England
od: Gathani, T, et al.
Izdano: (2021)

Ethnicity and the tumour characteristics of breast cancer in a large nationally representative sample of women in England
od: Gathani, T, et al.
Izdano: (2016)

Current evidence about the effect of hormone replacement therapy on the incidence of major conditions in postmenopausal women.
od: Beral, V, et al.
Izdano: (2005)

Female Reproductive Hormone Therapy: Risks and Benefits
od: Gathani, T, et al.
Izdano: (2009)

Hormone replacement therapy increase breast cancer incidence and may increase breast cancer mortality in postmenopausal women
od: Beral, V, et al.
Izdano: (2004)

Lung cancer in never smokers in the UK Million Women Study
od: Pirie, K, et al.
Izdano: (2016)

Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study.
od: Travis, R, et al.
Izdano: (2010)

Ovarian cancer and hormone replacement therapy - Reply
od: Beral, V, et al.
Izdano: (2007)

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.
od: Beral, V
Izdano: (1997)

Gene-Environment Interactions in 7610 Women With Breast Cancer: Prospective Evidence From the Million Women Study
od: Travis, R, et al.
Izdano: (2010)

GENE-ENVIRONMENT INTERACTIONS IN 7610 WOMEN WITH BREAST CANCER: PROSPECTIVE EVIDENCE FROM THE MILLION WOMEN STUDY
od: Travis, R, et al.
Izdano: (2010)

Persistent effects of women's parity and breastfeeding patterns on their body mass index: Results from the Million Women Study
od: Bobrow, K, et al.
Izdano: (2013)

Persistent effects of women's parity and breastfeeding patterns on their body mass index: results from the Million Women Study.
od: Bobrow, K, et al.
Izdano: (2013)

Histological type as a predictor of ovarian cancer survival in the million women study
od: Hermon, C, et al.
Izdano: (2018)

Hormone replacement therapy and high incidence of breast cancer between mammographic screens.
od: Beral, V, et al.
Izdano: (1997)

Fracture incidence in relation to the pattern of use of hormone therapy in postmenopausal women.
od: Banks, E, et al.
Izdano: (2004)

Cellular telephone use and the risk of brain tumors: update of the UK Million Women Study
od: Schüz, J, et al.
Izdano: (2022)

Reproductive factors and risk of oesophageal and gastric cancer in the Million Women Study cohort.
od: Green, J, et al.
Izdano: (2012)

Reproductive factors and risk of oesophageal and gastric cancer in the Million Women Study cohort
od: Green, J, et al.
Izdano: (2012)